Stockreport

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Beyond Air, Inc.  (XAIR) 
PDF GARDEN CITY, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmace [Read more]